<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02322502</url>
  </required_header>
  <id_info>
    <org_study_id>14-073</org_study_id>
    <nct_id>NCT02322502</nct_id>
  </id_info>
  <brief_title>Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia</brief_title>
  <official_title>Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia: a Randomized Multicenter Controlled Trial (ACC Baxter)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is first to assess if desflurane is superior in order to achieve a
      faster emergence from anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is first to assess if desflurane is superior in order to achieve a
      faster emergence from anesthesia (stating the date of birth) and second if desflurane is
      non-inferior in the occurrence of airway complications compared to sevoflurane or total
      intravenous anesthesia with propofol in the setting of laryngeal mask airway.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time of emergence from anesthesia</measure>
    <time_frame>up to 15 minutes</time_frame>
    <description>time of emergence from anesthesia defined as time between cessation of anesthesia until patient is able to state his/her date of birth on command</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Airway reactions (Incidence of intraoperative coughs, laryngospasm)</measure>
    <time_frame>up to 2 hours</time_frame>
    <description>Incidence of intraoperative coughs (induction/maintenance) - non-inferiority design Incidence of intraoperative laryngospasm (induction/maintenance) Incidence of cough at emergence Incidence of laryngospasms at emergence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergence times</measure>
    <time_frame>up to 15 minutes</time_frame>
    <description>Time to remove laryngeal mask Time to open eyes on command Time to respond on command (press hand) Time to state the name on command Recovery Index (RI = 1 + Aldrete5min/[(2xextubation time) + 1 x opening eyes time)]</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">352</enrollment>
  <condition>Anesthesia With Use of LMA (Laryngeal Mask Airway)</condition>
  <arm_group>
    <arm_group_label>desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Suprane® Dose: 0.8 MAC / 4-5 vol. % Mode of administration: inhalation with laryngeal mask One application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane:
Dose: 0.8 MAC / 1.2-1.4 vol.% Mode of administration: inhalation with laryngeal mask One application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol Dose: 5-7 mg kg-1 h-1 to maintain a BIS index value between 40 and 60 Mode of administration: intravenous One application</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>inhalation with laryngeal mask to maintain anaesthesia</description>
    <arm_group_label>desflurane</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>inhalation with laryngeal mask to maintain anaesthesia</description>
    <arm_group_label>sevoflurane</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>intravenous injection to maintain anaesthesia</description>
    <arm_group_label>propofol</arm_group_label>
    <other_name>Anesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned anesthesia with use of LMA (laryngeal mask airway)

          -  Planned duration of anesthesia between 0.5 and 2 hours

          -  Age between 18-75 years

          -  Both gender

          -  Body mass index (BMI) &lt;35

          -  ASA 1-3

          -  Written informed consent prior to study participation

        Exclusion Criteria:

          -  Planned additional regional and local anesthesia

          -  Contra-indication for the use of a laryngeal mask airway

          -  Asthma

          -  COPD IV

          -  Known allergy or hypersensitivity to any drugs administered during this study

          -  Women who are pregnant, breast-feeding or women of childbearing potential not using
             adequate contraceptive methods

          -  Participation in a drug or device trial within the previous 30 days.

          -  Patients legally unable to give written informed consent.

          -  Patients with severe psychiatric disorders

          -  Recent (&lt;6 months) history of alcohol or drug abuse

          -  Patients with severe neuropsychiatric disorders

          -  Non-fluency in German language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Coburn, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RWTH Aachen University; Department of Anesthesia</name>
      <address>
        <city>Aachen</city>
        <zip>D-52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martha-Maria Hospital Halle Dölau gGmbH, Department of Anesthesia</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskliniken Reutlingen, Department of Anesthesia</name>
      <address>
        <city>Reutlingen</city>
        <zip>73764</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ulm, Department of Anesthesia</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>October 5, 2016</last_update_submitted>
  <last_update_submitted_qc>October 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laryngeal mask airway</keyword>
  <keyword>desflurane</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>propofol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

